Columbia University

Memorial Sloan Kettering Cancer Center

Medicinova, Inc.

Grazia Ambrosini

Gary K Schwartz

Kazuko Matsuda

Richard Carvajal

Alex J Rai

Raya Khanin

Gary K Schwartaz

A method of preventing metastasis of a cancer in a patient in need thereof includes administering to the patient a therapeutically effective amount of ibudilast, or a pharmaceutical salt thereof.

Methods of preventing cancer metastasis

The present invention relates to methods and compositions for determining the likelihood that a subject suffering from a cancer will benefit from treatment with a MEK inhibitor. It also relates to methods of treatment based on such determination. The invention is based, at least in part, on the discoveries that DDX43 mRNA and protein are expressed at high levels in biopsies from 'non-responder' UM patients and that selumetinib-resistant cell lines showed high DDX43 expression which correlated with increased expression and activity of RAS. It was found that KRAS and HRAS but not NRAS, mediated expression of pERK and pAKT, bypassing oncogenic GNAQ. The invention is further based on the discovery that selumetinib-resistant cells became sensitive to AKT inhibition, suggesting alternative strategies for the treatment of cancer patients with acquired resistance to MEK inhibitors.

DDX43 as a biomarker of resistance to MEK1/2 inhibitors

Growing community of inventors

Astoria, NY, United States of America

Grazia Ambrosini